Mayil Vahanan Natarajan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mayil Vahanan Natarajan has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
A. Sivaseelam
M.N. Orthopaedic Hospital, Chennai, India
4 shared publicationsG. Rajkumar
MN Orthopaedic Hospital
3 shared publicationsA Sivaseelam
M.N. Orthopaedic Hospital, Kilpauk, Chennai, India
2 shared publicationsM. Paraskumar
M.N. Orthopaedic Hospital, Chennai, India
2 shared publicationsS. Natarajan
M.N. Orthopaedic Hospital, Chennai, India
2 shared publicationsAk Kumar
1 shared publication
Latest Publications
- 25 March 2006
- Published by Springer Nature in International Orthopaedics
- Vol. 30 (3) , 158-162
Custom mega-prosthetic replacement for proximal humeral tumours
We used custom mega-prostheses in 57 patients with aggressive benign and malignant tumours of the proximal humerus. The most common tumour was osteosarcoma, followed by giant cell tumour and chondrosarcoma. We achieved extra-articular and wide resection margins in all primary malignant tumours and narrow margins in benign and metastatic tumours. Six patients died of disease, 4 patients developed local recurrences and 43 were continuously disease free at an average follow-up of 5.5 years (range 2–14.5 years). Five patients required revision replacements. The most common complications were proximal subluxation and aseptic loosening. Functional outcome was satisfactory in 78% of cases.
- 25 March 2006
- Published by Springer Nature in International Orthopaedics
- Vol. 30 (3) , 158-162
Custom mega-prosthetic replacement for proximal humeral tumours
We used custom mega-prostheses in 57 patients with aggressive benign and malignant tumours of the proximal humerus. The most common tumour was osteosarcoma, followed by giant cell tumour and chondrosarcoma. We achieved extra-articular and wide resection margins in all primary malignant tumours and narrow margins in benign and metastatic tumours. Six patients died of disease, 4 patients developed local recurrences and 43 were continuously disease free at an average follow-up of 5.5 years (range 2–14.5 years). Five patients required revision replacements. The most common complications were proximal subluxation and aseptic loosening. Functional outcome was satisfactory in 78% of cases.
- 31 August 2005
- Published by Springer Nature in International Orthopaedics
- Vol. 29 (5) , 309-313
Distal femoral tumours treated by resection and custom mega-prosthetic replacement
We have analysed the results of 246 cases of distal femoral tumours treated by resection and prosthetic replacement between 1988 and 2002. Patient ages ranged from 6–67 years averaging 24 years; 133 were males. The most common tumour was osteosarcoma (67% of patients). The follow-up ranged from 2 to 14 years. Stage II tumours were seen in 72% of patients. The technique of sleeve resection of the quadriceps musculature was followed to achieve local clearance of the tumour. The prosthesis used was a rotating hinge custom mega-prosthesis manufactured locally. The functional result achieved was excellent or good in 87%; 86% of the patients had no evidence of disease, and 13% had died. The 10-year patient survival was 76.9%. Periprosthetic fracture and infection were the most common complications.
- 31 August 2005
- Published by Springer Nature in International Orthopaedics
- Vol. 29 (5) , 309-313
Distal femoral tumours treated by resection and custom mega-prosthetic replacement
We have analysed the results of 246 cases of distal femoral tumours treated by resection and prosthetic replacement between 1988 and 2002. Patient ages ranged from 6–67 years averaging 24 years; 133 were males. The most common tumour was osteosarcoma (67% of patients). The follow-up ranged from 2 to 14 years. Stage II tumours were seen in 72% of patients. The technique of sleeve resection of the quadriceps musculature was followed to achieve local clearance of the tumour. The prosthesis used was a rotating hinge custom mega-prosthesis manufactured locally. The functional result achieved was excellent or good in 87%; 86% of the patients had no evidence of disease, and 13% had died. The 10-year patient survival was 76.9%. Periprosthetic fracture and infection were the most common complications.
- Open Access
- 1 December 2004
- Published by SAGE Publications in Journal of Orthopaedic Surgery
- Vol. 12 (2) , 243-247
Paget's Sarcoma: Limb Salvage by Custom Mega Prosthesis: Four Case Reports
Of 4 Paget's sarcoma patients (age range, 55–68 years) underwent limb salvage surgery by custom mega prosthesis, 3 had lesions in the upper extremity and one in the proximal femur. Three of the patients were at stage IIB of the disease, according to Enneking's system of staging musculoskeletal tumours. All 4 patients underwent wide resection with a mean length of 152.5 mm. The defects were reconstructed with custom-made prostheses: proximal humeral prostheses in 2 of the patients, total elbow prosthesis in one, and total hip prosthesis in one. During a mean postoperative follow-up period of 40 months, one died of disseminated disease 14 months after surgery; one remained disease-free; 2 had local recurrence and required amputation, of whom one died of disseminated disease one year after amputation, the other had no further evidence of the disease. We report the functional outcomes of the 2 patients who were alive at the latest follow-up. The 2-year patient survival rate was 50%.
- 1 December 2004
- Published by SAGE Publications in Journal of Orthopaedic Surgery
- Vol. 12 (2) , 243-247
Open AccessPaget's Sarcoma: Limb Salvage by Custom Mega Prosthesis: Four Case Reports
Of 4 Paget's sarcoma patients (age range, 55–68 years) underwent limb salvage surgery by custom mega prosthesis, 3 had lesions in the upper extremity and one in the proximal femur. Three of the patients were at stage IIB of the disease, according to Enneking's system of staging musculoskeletal tumours. All 4 patients underwent wide resection with a mean length of 152.5 mm. The defects were reconstructed with custom-made prostheses: proximal humeral prostheses in 2 of the patients, total elbow prosthesis in one, and total hip prosthesis in one. During a mean postoperative follow-up period of 40 months, one died of disseminated disease 14 months after surgery; one remained disease-free; 2 had local recurrence and required amputation, of whom one died of disseminated disease one year after amputation, the other had no further evidence of the disease. We report the functional outcomes of the 2 patients who were alive at the latest follow-up. The 2-year patient survival rate was 50%.
- 26 August 2004
- Published by Springer Nature in International Orthopaedics
- Vol. 28 (5) , 307-310
Limb salvage in aggressive and malignant tumours of the fibula
We treated 25 patients with aggressive and malignant fibular tumours between April 1989 and May 2001. There were 11 osteosarcomas, seven Ewing's sarcoma and five chondrosarcomas. The tumours predominantly involved the upper one third; 16 were of Stage IIB. Neo-adjuvant and adjuvant chemotherapy were given to all patients with osteosarcoma and Ewing's sarcoma. In 20 patients, surgical margins were wide and in three radical. Mean follow-up was 71 (26-168) months. Local recurrences were met with in three patients requiring amputation. Three patients died of disease and one was lost to follow-up. Functional outcome was excellent in 12 patients and good in seven. The 5- and 10-year survival rates of patient and limb are reported based on Kaplan-Meier survival analysis.
- 26 August 2004
- Published by Springer Nature in International Orthopaedics
- Vol. 28 (5) , 307-310
Limb salvage in aggressive and malignant tumours of the fibula
We treated 25 patients with aggressive and malignant fibular tumours between April 1989 and May 2001. There were 11 osteosarcomas, seven Ewing's sarcoma and five chondrosarcomas. The tumours predominantly involved the upper one third; 16 were of Stage IIB. Neo-adjuvant and adjuvant chemotherapy were given to all patients with osteosarcoma and Ewing's sarcoma. In 20 patients, surgical margins were wide and in three radical. Mean follow-up was 71 (26-168) months. Local recurrences were met with in three patients requiring amputation. Three patients died of disease and one was lost to follow-up. Functional outcome was excellent in 12 patients and good in seven. The 5- and 10-year survival rates of patient and limb are reported based on Kaplan-Meier survival analysis.
- 1 December 2003
- Published by Springer Nature in International Orthopaedics
- Vol. 27 (6) , 334-337
Custom megaprosthetic replacement for proximal tibial tumours
- 1 December 2003
- Published by Springer Nature in International Orthopaedics
- Vol. 27 (6) , 334-337
Custom megaprosthetic replacement for proximal tibial tumours
- 26 March 2003
- Published by Springer Nature in International Orthopaedics
- Vol. 27 (3) , 175-179
Proximal femoral reconstruction with custom mega prosthesis
Seventy-seven patients with proximal femoral tumours underwent limb salvage surgery with custom mega prostheses between July 1989 and January 2002. We describe 44 cases with a mean follow-up of 57.8 months. Forty-one patients presented with malignant neoplasms of which 11 were malignant giant cell tumours, eight were chondrosarcoma and five were metastases. Wide margins were achieved for all malignant tumours, and marginal resection was done for all benign and metastatic lesions. Six patients died of disease and two were lost to follow-up. Mechanical complications were observed in six cases, fracture being the most common. Oncological complications occurred in five patients. Functional activity was satisfactory in 79% of patients.
- 26 March 2003
- Published by Springer Nature in International Orthopaedics
- Vol. 27 (3) , 175-179
Proximal femoral reconstruction with custom mega prosthesis
Seventy-seven patients with proximal femoral tumours underwent limb salvage surgery with custom mega prostheses between July 1989 and January 2002. We describe 44 cases with a mean follow-up of 57.8 months. Forty-one patients presented with malignant neoplasms of which 11 were malignant giant cell tumours, eight were chondrosarcoma and five were metastases. Wide margins were achieved for all malignant tumours, and marginal resection was done for all benign and metastatic lesions. Six patients died of disease and two were lost to follow-up. Mechanical complications were observed in six cases, fracture being the most common. Oncological complications occurred in five patients. Functional activity was satisfactory in 79% of patients.
- Open Access
- 1 December 2002
- Published by SAGE Publications in Journal of Orthopaedic Surgery
- Vol. 10 (2) , 203-205
Using a Custom Mega Prosthesis to Treat Hydatidosis of Bone: A Report of 3 Cases
Three cases of hydatidosis of bone with pathological fracture were treated by wide resection, custom mega prosthesis replacement, and chemotherapy. Two patients were females and one was male, with a mean age of 47 years (range, 38–55 years). Two of them had a pathological fracture of the proximal femur, and one had a pathological fracture of the distal femur. All patients were treated postoperatively with albendazole 400mg, twice daily, for 12 weeks. During the mean follow-up period of 4.5 years, no recurrence of Echinococcal infection was noticed. The use of the custom mega prosthesis technique has not been reported elsewhere, and hydatid disease of the bone can now be considered an extended indication for custom mega prosthesis in addition to its application in surgery for tumours and massive trauma.
- 1 December 2002
- Published by SAGE Publications in Journal of Orthopaedic Surgery
- Vol. 10 (2) , 203-205
Open AccessUsing a Custom Mega Prosthesis to Treat Hydatidosis of Bone: A Report of 3 Cases
Three cases of hydatidosis of bone with pathological fracture were treated by wide resection, custom mega prosthesis replacement, and chemotherapy. Two patients were females and one was male, with a mean age of 47 years (range, 38–55 years). Two of them had a pathological fracture of the proximal femur, and one had a pathological fracture of the distal femur. All patients were treated postoperatively with albendazole 400mg, twice daily, for 12 weeks. During the mean follow-up period of 4.5 years, no recurrence of Echinococcal infection was noticed. The use of the custom mega prosthesis technique has not been reported elsewhere, and hydatid disease of the bone can now be considered an extended indication for custom mega prosthesis in addition to its application in surgery for tumours and massive trauma.
- Open Access
- 19 September 2001
- Published by Springer Nature in International Orthopaedics
- Vol. 25 (5) , 335
Author’s reply
- 19 September 2001
- Published by Springer Nature in International Orthopaedics
- Vol. 25 (5) , 335
Open AccessAuthor’s reply
- 15 February 2001
- Published by Springer Nature in International Orthopaedics
- Vol. 25 (2) , 107-109
The Saddle prosthesis in periacetabular tumours
- 15 February 2001
- Published by Springer Nature in International Orthopaedics
- Vol. 25 (2) , 107-109
The Saddle prosthesis in periacetabular tumours